VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 712 filers reported holding VANECK VECTORS ETF TR in Q4 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,000,442 | +48.6% | 185,821 | +66.3% | 0.06% | +12.7% |
| Q2 2023 | $3,365,133 | -20.0% | 111,761 | -14.1% | 0.06% | -23.6% |
| Q1 2023 | $4,207,858 | +21.2% | 130,073 | +7.4% | 0.07% | +7.5% |
| Q4 2022 | $3,471,959 | +36.8% | 121,143 | +15.0% | 0.07% | +17.5% |
| Q3 2022 | $2,538,000 | -15.1% | 105,370 | -3.7% | 0.06% | -9.5% |
| Q2 2022 | $2,989,000 | -31.6% | 109,385 | -4.0% | 0.06% | +5.0% |
| Q1 2022 | $4,368,000 | +48.1% | 113,898 | +23.7% | 0.06% | -22.1% |
| Q4 2021 | $2,949,000 | -8.4% | 92,056 | -15.7% | 0.08% | -2.5% |
| Q3 2021 | $3,220,000 | +184.5% | 109,265 | +227.9% | 0.08% | +97.5% |
| Q2 2021 | $1,132,000 | – | 33,320 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |